Stage 1

Discovery and preclinical strategy

Tools for defining the target product, selecting candidates and connecting scientific evidence to development decisions.

What this stage covers

Target product strategy, candidate selection, translational planning, ADME/DMPK, and pharmacology governance.

How it helps your team: Make early development choices clearer, traceable, and easier to defend.

5 toolkits

Choose the operational area you need

1.1

Define what the product is intended to become and how development decisions support that goal.

1.2

Decide whether a candidate is ready to enter formal development.

1.3

Link mechanism, biology, pharmacology, biomarkers, and clinical rationale.

1.4

Plan and govern absorption, distribution, metabolism, excretion, PK, and exposure evidence.

1.5

Manage pharmacology studies supporting proof of concept, dose rationale, and clinical translation.

Return to the full catalogue and search by process, study, submission or control.